CARE for Women: Investing in Care Delivery to Improve Women’s Lives and Livelihoods

Why It Matters

Improving women’s care delivery directly reduces morbidity and unlocks substantial economic gains, making it a strategic priority for health systems and policymakers.

Key Takeaways

• Care‑delivery gaps cause one‑third of women’s health disparity.
• Closing gaps could prevent 70,000 U.S. medical events.
• CARE framework guides research, alignment, reporting, engagement.
• Improved screening could give women 2.5 healthier days yearly.
• Economic gain up to $43 billion annually by 2040.

Pulse Analysis

Women’s health outcomes lag behind men’s largely because evidence‑based practices are not consistently applied. The report quantifies this shortfall, showing that 34 % of the overall health disparity is tied to delivery failures—from missed screenings for breast arterial calcification to inadequate postpartum cardiovascular monitoring. By translating clinical insights into actionable pathways, stakeholders can target the most preventable events, shifting the narrative from reactive treatment to proactive risk management. This shift not only improves individual well‑being but also addresses the broader public‑health burden that has persisted despite advances in medical knowledge.

The CARE framework—Conduct, Align, Report, Engage—offers a pragmatic roadmap for health systems seeking to bridge these gaps. Conducting targeted research fills the data void around sex‑specific disease markers, while aligning care integrates fragmented referral networks across specialties such as cardiology, obstetrics and mental health. Clear reporting standards ensure that findings like breast arterial calcification are consistently documented and acted upon, and patient engagement empowers women to participate actively in their care journeys. Applying this framework across the three highlighted pathways demonstrates how modest improvements in screening and follow‑up can translate into millions of disability‑adjusted life years saved.

Beyond clinical benefits, the economic case is compelling. Modeling predicts up to $43 billion in annual gains by 2040 if gender gaps in ischemic heart disease are closed, reflecting reduced hospitalizations, higher productivity, and lower long‑term care costs. Policymakers can leverage these insights to prioritize funding for standardized protocols, incentivize cross‑disciplinary collaboration, and embed gender‑responsive metrics into performance dashboards. As health systems adopt the CARE principles, they position themselves to deliver higher‑value care, strengthen workforce confidence, and ultimately drive a healthier, more productive female population worldwide.